Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MIS12 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | HMGN1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | CCDC151 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | PTBP3 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | PLA2G4B | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | ARAF | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | DNAJC30 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | LRP5 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | AC011530.4 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | ETV3 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |